Southwest Research Institute (SwRI) and St. Mary’s University have embarked on a groundbreaking collaboration aimed at revolutionizing the future of hydrogen storage technology. This joint venture seeks to develop a comprehensive, physics-based forecasting tool capable of predicting the degradation and long-term durability of titanium-iron (TiFe)-based metal hydride vessels. Leveraging a chemical and thermo-mechanical modeling framework, the project represents a significant leap forward in tackling one of the most persistent challenges in hydrogen storage materials science. This initiative is made possible through a $125,839 grant from the St. Mary’s-SwRI Technology and Applied Research (S²TAR) Program, designed to foster impactful research collaborations.

Metal hydrides are pivotal materials in the hydrogen energy landscape, serving as one of the few safe and compact solid-state options for hydrogen storage. These materials function by chemically binding hydrogen to metal lattices through chemisorption, effectively locking hydrogen atoms within the structure. Unlike high-pressure gaseous tanks or cryogenic liquid hydrogen storage, metal hydrides offer improved safety profiles and reduce energy-intensive requirements. However, despite these advantages, their widespread application is hindered by their limited durability and performance degradation resulting from repeated hydrogen absorption and desorption cycles.

At the heart of this ambitious research endeavor is the intricate problem of metal hydride vessel degradation. Over numerous charge and discharge cycles, physical changes ensue within the alloy powders comprising the metal hydride bed. These changes include fracturing of particles, densification of the powder bed, and mechanical stresses that collectively impair hydrogen storage capacity and vessel performance. Traditional evaluation methods rely heavily on prolonged, costly experimental testing to assess long-term vessel integrity—a bottleneck that impedes innovation and commercialization.

The project team, headed by Dr. Richard S. Fu of SwRI and Dr. Mohamed Shaat of St. Mary’s University, seeks to transcend these limitations by integrating advanced physics-based simulations with targeted experimental validation. This dual approach aims to create a robust modeling framework capable of forecasting the lifecycle and operational durability of TiFe metal hydride vessels. The predictive tool will account for the coupled chemical, thermal, and mechanical phenomena driving hydrogen cycling performance over hundreds or even thousands of cycles.

Dr. Shaat is spearheading the development of an intricate, multiphysics computational framework at St. Mary’s University. This model is designed to encapsulate the complex interplay between hydrogen diffusion, chemisorption reactions, phase transformations within the metal hydride, heat generation and transfer, and the evolution of mechanical stress within the vessel. By accurately simulating these interconnected processes, the framework seeks to facilitate precise performance predictions, while also identifying design parameters and operational regimes that optimize both efficiency and vessel longevity.

Central to the team’s vision is the translation of fundamental physical and chemical principles of hydrogen interaction into computationally efficient predictive models. Dr. Shaat emphasizes the importance of capturing the coupling mechanisms—particularly how hydrogen transport influences thermal and mechanical responses and vice versa—in order to provide reliable simulations that replace and reduce the dependence on lengthy physical testing. This innovative approach promises to significantly reduce costs, accelerate development cycles, and improve hydrogen storage system designs.

On the experimental front, SwRI’s team, under Dr. Fu’s guidance, is undertaking controlled, long-term cycling experiments to collect essential validation data. By subjecting metal hydride vessels to realistic charge-discharge scenarios, they aim to quantitatively monitor performance degradation mechanisms as they unfold. These experiments will provide the empirical backbone necessary to calibrate and refine the modeling framework, ensuring that simulation outputs faithfully represent real-world behavior under operational conditions.

The synergy between modeling efforts and experiments forms the cornerstone of the project’s iterative design loop. As Dr. Fu explains, modeling insights will direct the focus of experimental tests to critical phenomena, while the resulting data will feedback to correct and enhance the models. This dynamic interplay is expected to unravel previously obscure degradation mechanisms by illuminating the coupled chemical, thermal, and mechanical interactions at work within the metal hydride vessels. Ultimately, this feedback-driven methodology will yield a predictive tool capable of guiding material improvements and engineering decisions.

Hydrogen’s emergence as a clean, versatile energy carrier is a key cornerstone of global efforts to decarbonize energy and transportation sectors. However, to fulfill its potential, advances in storage technology are imperative. Unlike batteries or fossil fuels, hydrogen storage demands novel materials and engineering solutions due to its unique physical and chemical characteristics. By focusing on metal hydride vessels, this project addresses a promising yet underdeveloped storage pathway that could unlock safer, more efficient hydrogen deployment across diverse applications.

The S²TAR funding mechanism plays an instrumental role in enabling this interdisciplinary collaboration by providing seed resources that draw on the expertise strengths of both SwRI and St. Mary’s University. This partnership is not only poised to produce high-impact scientific outcomes but also lays the foundation for sustained cooperation. Through this collaboration, the team is well-positioned to attract larger external funding sources from federal agencies and industry players focused on advancing hydrogen infrastructure and clean energy technology.

As work progresses, the team anticipates that their predictive modeling tool will be an invaluable resource for the hydrogen storage community. It will offer designers and researchers an evidence-based platform to evaluate new materials, optimize vessel designs, and predict operational lifetimes with higher confidence. By systematically addressing the core durability challenges of metal hydride storage, this project represents a wide-reaching advancement that could significantly accelerate solid-state hydrogen storage adoption worldwide.

In conclusion, this joint initiative by Southwest Research Institute and St. Mary’s University epitomizes the cutting edge of hydrogen storage research. Through combining rigor in experimental validation and sophistication in physics-based modeling, the project champions a future where hydrogen is stored more safely and efficiently. The knowledge generated here promises to not only rewrite the fundamentals of storage vessel degradation understanding but also to catalyze practical applications in the global hydrogen economy.

Subject of Research: Physics-based modeling and experimental validation of TiFe-based metal hydride hydrogen storage vessel degradation and durability.

Article Title: Advancing Solid-State Hydrogen Storage: Predictive Modeling and Experimental Synergy for Metal Hydride Vessel Durability

News Publication Date: June 24, 2026

Web References: https://www.swri.org/markets/energy-environment/power-generation-utilities/advanced-power-systems/hydrogen-energy-research?&utm_medium=referral&utm_source=eurekalert!&utm_campaign=s2tar-metal-hydrides-pr

Image Credits: Southwest Research Institute

Keywords

Hydrogen storage, metal hydrides, TiFe alloys, chemisorption, physics-based modeling, thermo-mechanical framework, hydrogen diffusion, phase transformation, performance degradation, solid-state hydrogen storage, experimental validation, multiphysics simulations

In a groundbreaking study poised to reshape the landscape of inflammatory bowel disease (IBD) treatment, researchers at the University of Louisville have elucidated the molecular mechanisms by which a natural metabolite derived from dietary sources orchestrates a protective immune response in the gut. IBD, encompassing debilitating conditions such as Crohn’s disease and ulcerative colitis, affects millions globally and is characterized by persistent inflammation and compromised intestinal barrier integrity. The intestinal barrier plays a critical role in maintaining homeostasis by allowing nutrient absorption while preventing the translocation of harmful microbial agents. In patients with IBD, this barrier is disrupted, leading to exacerbated inflammation and tissue injury.

Central to this new discovery is urolithin A (UroA), a microbial metabolite produced in the human gut following the ingestion of ellagitannin-rich foods such as pomegranates, walnuts, and berries. The research team led by Dr. Venkatakrishna Rao Jala unveiled how UroA selectively activates the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor expressed in various cell types, including those that constitute the intestinal epithelium. Unlike conventional views of AHR as a mediator of toxicological responses to environmental contaminants, this study highlights a nuanced role for AHR signaling in immune modulation and barrier function maintenance.

In their experimental design, investigators employed a combination of cell culture models, intestinal organoids, and human tissue samples from IBD patients to delineate the cellular and molecular pathways engaged by UroA. This comprehensive approach allowed them to pinpoint intestinal epithelial cells as the primary sites of AHR activation by UroA. Activated epithelial AHR, in turn, stimulates the assembly of the NLRP6 inflammasome, a multiprotein complex traditionally associated with inflammatory cytokine maturation and pyroptotic cell death. Contrary to the canonical inflammatory paradigm, NLRP6 activation here initiates a controlled release of protective mediators that promote epithelial repair, mucus production, and antimicrobial peptide secretion, collectively enhancing barrier integrity.

This dualistic nature of inflammasome signaling reveals an elegant example of cellular context-determined outcomes of innate immune pathways. While systemic inflammasome activation is linked to pathological inflammation, its epithelial-specific engagement appears to serve as a homeostatic mechanism preserving mucosal immunity and preventing microbial dysbiosis. This insight furthers our understanding of the immune microenvironment in the gut and challenges existing dogmas that broadly classify inflammatory signaling as detrimental in chronic intestinal diseases.

The exploration of UroA’s mechanism also sheds light on the intricacies of diet-microbiota-host interactions that underpin gut health. Dietary metabolites have emerged as critical modulators of signaling networks that maintain tissue equilibrium. This study positions urolithin A as a pivotal molecular bridge linking dietary intake to cellular defense strategies, mediated through receptor-mediated inflammasome activation. By elucidating this axis, the findings offer a compelling rationale for dietary or microbiota-targeted interventions designed to harness endogenous metabolites for therapeutic benefit.

Importantly, the protective pathway abrogates damage caused by intestinal injury without invoking broad immunosuppression, a common drawback of current IBD therapies that can predispose patients to infections and malignancies. Targeted activation of epithelial AHR by UroA selectively augments mucosal barrier function while modulating local immunity, offering a precision medicine approach with potentially fewer side effects.

From a translational perspective, these insights could catalyze the development of novel therapeutics that mimic or potentiate UroA’s activity, aiming to restore gut barrier homeostasis in individuals suffering from IBD and other gastrointestinal disorders. Unlike systemic immunomodulators, such agents could enhance intrinsic repair mechanisms, reinforcing the mucosal shield against microbial translocation and inflammation relapse.

Furthermore, this research underscores the importance of endothelial and epithelial cellular compartments in orchestrating immune responses that are finely tuned to environmental and nutritional cues. The aryl hydrocarbon receptor emerges as a nodal point integrating extrinsic and intrinsic signals, modulating inflammasome dynamics uniquely in epithelial cells as opposed to immune cells such as macrophages or dendritic cells, where AHR activation may produce opposing outcomes.

The team’s validation using human intestinal biopsies strengthens the clinical relevance of their findings, demonstrating that UroA-induced AHR-NLRP6 activation is not merely an experimental artifact but a genuine biological phenomenon with implications in human disease states. The investigation also highlights the potential inter-individual variability in microbiota capacity to generate UroA, which may influence susceptibility or response to treatment in IBD patients.

Concluding remarks from the lead investigators emphasize the broader implications of delineating this pathway. By distinguishing harmful from beneficial inflammatory cascades, the study advocates for selective immunomodulation strategies that leverage inherent protective mechanisms instead of indiscriminate suppression. This paradigm shift could revolutionize therapeutic approaches, fostering better clinical outcomes and improved quality of life for those affected by chronic intestinal inflammation.

Collectively, these findings mark a significant advance in gut immunology and open new avenues for precision dietary-based therapeutics. The interaction between diet-derived microbial metabolites, host epithelial signaling, and inflammasome activation represents a complex yet promising frontier in combating chronic inflammatory diseases. As our understanding deepens, integrating nutritional sciences with immunopharmacology may yield innovative treatments that redefine gut health maintenance.

Subject of Research: Human tissue samples

Article Title: Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity

News Publication Date: 23-Jun-2026

Web References: http://dx.doi.org/10.1038/s41467-026-73760-3

References: Published in Nature Communications

Image Credits: University of Louisville

Keywords: Human gut microbiota, Metabolism, Metabolomics, Metabolites, Diseases and disorders, Digestive disorders, Inflammatory bowel diseases, Gastrointestinal tract, Gastrointestinal disorders, Inflammasomes

In the ongoing battle against obesity and its associated cardiovascular risks, new scientific insights are shedding light on the complex interplay between weight loss strategies and vascular health. Recent research from the S-LiTE trial, presented in a landmark study by Sandsdal et al., unfolds groundbreaking findings on how exercise and the GLP-1 receptor agonist liraglutide profoundly influence vascular function and systemic inflammation during weight loss maintenance. This investigation not only advances our understanding of therapeutic approaches but also charts a promising path for improving cardiovascular outcomes in individuals struggling with obesity.

Obesity, recognized as a critical driver of cardiovascular disease, involves pathological alterations in the vascular system and chronic low-grade inflammation. These pathological changes elevate the risk of atherosclerosis, hypertension, and ultimately, heart failure. Consequently, effective weight loss maintenance after initial reductions is paramount for sustaining vascular benefits and mitigating long-term health risks. Despite existing weight loss regimens, relapse rates are high, and how these interventions impact vascular integrity during the maintenance phase remains incompletely understood. The S-LiTE trial rigorously targeted this knowledge gap, merging pharmacological and lifestyle components for a nuanced examination.

Exercise has been universally endorsed as a cornerstone intervention in weight management and cardiovascular disease prevention. Its benefits extend beyond simple calorie expenditure, encompassing modulation of endothelial function, arterial stiffness, and inflammatory profiles. Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has garnered attention for its potent weight-lowering effects through appetite regulation and metabolic improvements. However, the independent and combined vascular effects of exercise and liraglutide during the maintenance phase after weight loss had yet to be elucidated prior to this study.

The S-LiTE trial meticulously randomized participants who had achieved significant weight reduction to either an exercise program, liraglutide treatment, a combination of both, or placebo, allowing for a comprehensive comparison across groups. Over the course of the trial, vascular health parameters such as carotid artery compliance, endothelial function assessed via flow-mediated dilation, and systemic inflammatory markers including C-reactive protein (CRP) and interleukins were closely monitored. The multidimensional assessment unveiled striking differences attributable to intervention modalities.

Exercise alone was associated with notable improvements in arterial compliance and a favorable reduction in markers of vascular inflammation. The mechanical stimuli generated during physical activity promote shear stress on vessel walls, which in turn enhance nitric oxide bioavailability and endothelial repair mechanisms. These physiological adaptations are critical for maintaining vascular elasticity and preventing atherogenic processes. This study underscores the indispensable role of exercise not just in weight regulation but as a direct modulator of vascular integrity.

Liraglutide, beyond its appetite-suppressant and glycemic control effects, demonstrated intrinsic vascular benefits. The study highlighted liraglutide’s capacity to enhance endothelial function independently of exercise, potentially through GLP-1 receptor-mediated pathways that reduce oxidative stress and inhibit pro-inflammatory signaling cascades. This offers compelling evidence supporting the use of GLP-1 receptor agonists as adjunct therapies in cardiovascular risk reduction within the obese population.

Intriguingly, the combination of exercise and liraglutide yielded additive benefits, with participants exhibiting the most pronounced improvements in vascular compliance and the greatest suppression of inflammatory cytokines. This synergistic effect suggests that the pharmacological and mechanical influences converge on complementary pathways, amplifying the overall vascular protective effect. Such findings advocate for integrative treatment frameworks that leverage both lifestyle and pharmacotherapy in obesity management.

Delving deeper, the study’s prespecified secondary analysis elucidated how these interventions influenced various immune cell populations that are pivotal contributors to vascular inflammation. It was evident that the combined approach modulated monocyte and macrophage activation states, steering them towards anti-inflammatory phenotypes. This immune modulation is instrumental in curbing chronic inflammation and subsequent endothelial dysfunction, which are foundational in the pathogenesis of vascular disease.

Beyond the vascular sphere, the inflammatory milieu impacts insulin sensitivity and adipose tissue dynamics, central to metabolic health. The study posits that improvements in vascular health might interplay with metabolic regulation, facilitating a virtuous cycle of weight loss maintenance and cardiovascular risk attenuation. This holistic perspective on obesity interventions highlights the interconnected nature of metabolism, immunity, and vascular function.

Crucial to real-world applicability, the study design mirrored long-term maintenance conditions, providing practical insights for clinicians. The sustainability of vascular improvements with continued exercise and pharmacological support affirms the need for ongoing adherence and monitoring. Moreover, the tolerability profile and patient-centered outcomes reported provide a realistic framework for incorporating such regimens in routine care.

This research not only emphasizes the potent vascular benefits tied to weight loss maintenance but also brings to light the nuanced biological effects of different modalities. The implications extend beyond cardiovascular disease prevention, touching on broader aspects of healthy aging and quality of life, as vascular health is integral to multiple organ systems. Hence, the S-LiTE trial’s findings hold substantial promise for shaping future clinical guidelines.

In the broader context of obesity treatment paradigms, these insights challenge the notion that weight loss alone is sufficient. Instead, they advocate for multidimensional interventions addressing vascular function and inflammation, which are crucial mediators of obesity-related morbidity. Such transformations in therapeutic strategies could pivot the field towards more personalized and mechanistically informed approaches.

While the study is robust, the authors acknowledge limitations including the homogeneity of the cohort and potential confounders inherent to lifestyle interventions. Future investigations are warranted to explore molecular signaling pathways in greater detail, diverse populations, and longer-term cardiovascular outcomes. Additionally, integrating imaging modalities and biomarker profiling could refine our understanding of treatment impacts at the microvascular level.

On a scientific and societal level, the S-LiTE trial represents a milestone in conceptualizing weight loss maintenance not simply as weight stabilization but as an active process with profound systemic effects. Public health strategies might evolve to promote combined regimens, potentially alleviating the healthcare burden posed by obesity-related vascular diseases. This research, therefore, stands at the confluence of basic science, clinical innovation, and health policy.

The findings from Sandsdal and colleagues’ work resonate with an emerging narrative in metabolic medicine: holistic, multimodal approaches yield superior benefits than isolated interventions. With obesity prevalence continuing to climb globally, translating these findings into accessible, scalable solutions remains both a challenge and an imperative. The S-LiTE trial ignites hope for more effective, durable solutions to one of the most pressing health crises of our time.

In summary, the S-LiTE trial reveals that exercise and liraglutide individually and synergistically improve vascular health and reduce inflammation during weight loss maintenance. This study offers compelling evidence for the inclusion of GLP-1 receptor agonists alongside structured exercise programs to sustain cardiovascular health in individuals maintaining weight loss. These innovative insights redefine obesity treatment and open new avenues for reducing the global burden of cardiovascular disease through integrated, targeted therapeutic strategies.

Subject of Research: Effects of exercise and GLP-1 receptor agonist liraglutide on vascular health and inflammation during weight loss maintenance.

Article Title: Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial.

Article References:
Sandsdal, R.M., Holt, J., Alkhefagie, H.G.A. et al. Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial. Nat Metab (2026). https://doi.org/10.1038/s42255-026-01554-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s42255-026-01554-4

Angela Rayner has been burnishing her Left-wing credentials this morning with a call for a hike in benefits as she joined other Labour big beasts in bidding to join Andy Burnham's top team.

The post Angela Rayner Calls for Benefits Hike in Bid to Join Burnham’s Team appeared first on The Daily Sceptic.